Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach
Michaël Maes, Walton Luiz Del Tedesco, Marcell Alysson Batisti Lozovoy, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1945-1955
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 127
Apolipoprotein C3 (ApoC3) facilitates NLRP3 mediated pyroptosis of macrophages through mitochondrial damage by accelerating of the interaction between SCIMP and SYK pathway in acute lung injury
Zhichen Pu, Wenhui Wang, Haitang Xie, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111537-111537
Closed Access | Times Cited: 19
The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
Abbas F. Almulla, Thitiporn Supasitthumrong, Chavit Tunvirachaisakul, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 60
Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity
Kajal Gupta, Gaganpreet Kaur, Tejal Pathak, et al.
Gene (2022) Vol. 844, pp. 146790-146790
Open Access | Times Cited: 54
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways
Michaël Maes, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 16, pp. 10362-10362
Open Access | Times Cited: 42
Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 511-511
Open Access | Times Cited: 38
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection
Hussein Kadhem Al‐Hakeim, Haneen Tahseen Al-Rubaye, Abdulsahib S Jubran, et al.
Brazilian Journal of Psychiatry (2023)
Open Access | Times Cited: 23
Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach
Dhurgham Shihab Al-Hadrawi, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
Acta Neuropsychiatrica (2022) Vol. 35, Iss. 2, pp. 76-87
Open Access | Times Cited: 35
Inflammation and oxidative stress in salt sensitive hypertension; The role of the NLRP3 inflammasome
Lale A. Ertuğlu, Ashley Pitzer Mutchler, Justin Yu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 29
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Jiaying Shen, Junyan Fan, Yue Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
NLRP3, the inflammasome and COVID-19 infection
Maureen Yin, Laura Marrone, Christian G. Peace, et al.
QJM (2023) Vol. 116, Iss. 7, pp. 502-507
Open Access | Times Cited: 17
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp
Nanyang Liu, Xuefan Jiang, Hao Li
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 14
Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib
Vanio Mitev
Pharmacia (2023) Vol. 70, Iss. 4, pp. 1177-1193
Open Access | Times Cited: 13
Immunopathogenesis and Immunogenetic Variants in COVID-19
Pakorn Sagulkoo, Kitiporn Plaimas, Apichat Suratanee, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 22, pp. 1780-1797
Closed Access | Times Cited: 21
Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors
Rominah Onintsoa Diarimalala, Yanhong Wei, Da Hu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 10
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury
Guilherme Pasetto Fadanni, João Β. Calixto
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 13-25
Closed Access | Times Cited: 10
Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19
Verónica Pulito‐Cueto, M. Sebastián Mora-Gil, Diego Ferrer‐Pargada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3731-3731
Open Access | Times Cited: 3
Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to LONG COVID: a precision nomothetic approach
Dhurgham Shihab Al-Hadrawi, Haneen Tahseen Al-Rubaye, Abbas F. Almulla, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Recuperative herbal formula Jing Si maintains vasculature permeability balance, regulates inflammation and assuages concomitants of “Long-Covid”
Chien-Yi Chiang, Yu‐Jung Lin, Wen‐Tsan Weng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114752-114752
Open Access | Times Cited: 7
Breaking Bad: Inflammasome Activation by Respiratory Viruses
Julia A. Cerato, Emanuelle F. da Silva, Bárbara N. Porto
Biology (2023) Vol. 12, Iss. 7, pp. 943-943
Open Access | Times Cited: 7
Ox-inflammasome involvement in neuroinflammation
Andrea Vallese, Valeria Cordone, Alessandra Pecorelli, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 161-177
Closed Access | Times Cited: 7
Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
Efthalia Angelopoulou, Eleni Karlafti, Vasiliki Georgakopoulou, et al.
Life (2023) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 6
Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil
Nathalia Beatriz Ramos de Sá, Milena Neira-Goulart, Marcelo Ribeiro-Alves, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top